Marijuana Stocks & Publicly Traded Cannabis Companies

Australian Cannabis Company Acquires Canadian MMJ Producer

Australian medical cannabis company PhytoTech Medical Limited has entered into a merger agreement with Canadian producer MMJ Biosciences Inc., making it the second publicly traded Australian company to enter the Canadian medical marijuana market this month. The merger will create MMJ-PhytoTech, a vertically integrated medical cannabis company, the companies said. PhytoTech, listed on the Australian […]

Read More

Medical Marijuana Inc Names New President, CEO

Medical Marijuana Inc. finally has a new man at the helm. Dr. Stuart Titus, Ph.D, has been named president and CEO of the publicly traded company, and will also serve as one of the board members. Titus is the first public leader of the company since former CEO Michael Llamas stepped down in 2012. He […]

Read More

News of Surna Exec’s Departure Triggers Stock Slide

Shares of Surna Inc. have dipped since the company announced that its high-profile CEO Tom Bollich will step down, continuing a longer stock slide that began a year ago. The cannabis cultivation technology firm said last week that Bollich will depart April 14 as the company moves from a startup to a more mature operation. […]

Read More

Chart of the Week: 2014 Performance of Cannabis Stocks By Quarter

By Marijuana Business Daily staff Cannabis stocks proved lucrative at the beginning of 2014, but the chances of a solid return deteriorated in the second half of the year. An investor who pumped money into a mix of securities followed by the Viridian Cannabis Stock Index in early January of last year could’ve netted a […]

Read More

Report: Outlook for MJ Stocks Strong, But Many Could Stumble

Institutional investors will put money into cannabis stocks this year, though many publicly traded MJ businesses could eventually fail because of poor fundamentals, according to a report from a New York-based investment firm and adviser. The report  – released by Viridian Capital Partners – says investors will increasingly scrutinize public cannabis companies, seeking strong management […]

Read More

HempMeds to Add 100 Employees as Part of Expansion

HempMeds, a subsidiary of Medical Marijuana Inc., is planning some aggressive moves to expand this year. The company said it expects to add roughly 100 employees in 2015 to its new San Diego headquarters – which currently has 52 workers – as it ramps up its Dixie Botanicals line of hemp-based CBD products. HempMeds acquired […]

Read More

Class-Action Lawsuits Send Medbox Shares Lower, Highlight Risks of Going Public

By John Schroyer Medbox Inc., one of the most prominent publicly traded companies in the cannabis space, is grappling with an issue that could become more common in the marijuana industry: class-action lawsuits. The suits, one filed on Jan. 16 and another on Jan. 28, are both based on allegations that the company engaged in […]

Read More

SEC Gives Green Light to Marijuana Company’s Stock Registration

The U.S. Securities and Exchange Commission has approved a share registration by a company that will engage in the cultivation and sale of marijuana, which could encourage other businesses that deal directly with cannabis to go public. It marks the first time the SEC has signed off on a share registration by a company that […]

Read More

Surna Acquires Majority Stake in Agrisoft for $4 Million

Two notable names in the cannabis industry are teaming up. Surna Inc., a publicly traded firm listed on the over-the-counter markets, has signed an agreement to acquire a 66% stake of Agrisoft Development Group to add a technology firm to its portfolio. Agrisoft, a closely held company, develops seed-to-sale tracking systems for state-regulated cannabis cultivators […]

Read More

Cannabis Sativa Adds Another Former Political Bigwig

Some say that business and politics don’t mix, but one cannabis company is betting they go together just fine. Cannabis Sativa – headed by former New Mexico Gov. Gary Johnson – announced that ex-Alaska Sen. Mike Gravel will head its subsidiary Kush, which develops infused products. Cannabis Sativa acquired Kush last summer. Gravel – a […]

Read More

Week in Review: Ruling on Delivery App, Boost for MMJ Stocks + MA Businesses Gearing Up

By John Schroyer and Tony C. Dreibus A smartphone app that facilitates medical marijuana deliveries is ordered to cease operations in Los Angeles, two publicly traded companies help build credibility for cannabis stocks, and Massachusetts MMJ businesses move forward in the face of regulatory uncertainty. Here’s a closer look at some notable developments in the […]

Read More

GW Pharmaceuticals Added to Nasdaq Biotech Index

GW Pharmaceuticals, a United Kingdom-based company that develops CBD-rich treatments, has been added to the Nasdaq Biotechnology Index (NBI). The NBI tracks the performance of a set of securities traded on the exchange that are classified as biotech or pharmaceutical companies. GW Pharmaceuticals is the developer of Sativex, a cannabis-based drug that is approved in […]

Read More